Autopsy report · NCT03372603

A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough

“Study terminated due to lack of efficacy of GSK2798745 in chronic cough.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 6 months before it stopped.
• 17 participants enrolled.
• Results were posted on the registry 1 year after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

GlaxoSmithKline

Sponsor type

Industry

Conditions

Cough

Interventions

GSK2798745; Placebo

Participants

17

Sites

8

Countries

United Kingdom

Trials that died the same way

• A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
  “The study was terminated due to the discontinuation of the tralokinumab asthma program (as per the results of the Phase III study \[D2210C00008\])” (58% match in meaning)
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
  “This study was terminated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.